Andrew Reardon, CLO & Secretary: Ligand Pharmaceuticals LGND Planned sale · Filed 03/04

Trade details

Type: Planned sale notice
Stock: Ligand Pharmaceuticals LGND
Person: Andrew ReardonCLO & Secretary
Planned sale date: 26/03/04
Filed: 26/03/04

0.1% of shares outstanding to be sold

Ligand Pharmaceuticals trades, last 26 weeks

What else happened in Ligand Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/02~04/03

Andrew Reardon's recent trades

Andrew ReardonCLO & Secretary
Planned sale10b5-1 planLigand Pharmaceuticals
Planned sale10b5-1 plan
Ligand Pharmaceuticals
LGND
$4.3M
15,000 sh
$4.3M
Filed 09/03
Traded 09/03
Andrew ReardonCLO & Secretary
Planned sale10b5-1 planLigand Pharmaceuticals
Planned sale10b5-1 plan
Ligand Pharmaceuticals
LGND
$3.2M
10,000 sh
$3.2M
Filed 07/01
Traded 07/01
Andrew ReardonCLO & Secretary
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$323.6K
1,432 sh
$323.6K
Filed 06/02
Traded 06/01
Andrew ReardonCLO & Secretary
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$279K
1,216 sh
$279K
Filed 06/02
Traded 06/01
Andrew ReardonCLO & Secretary
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$152.5K
677 sh
$152.5K
Filed 06/02
Traded 06/01

Andrew Reardon, CLO — plans to sell 20,000 sh of Ligand Pharmaceuticals LGND · $4.1M · around 03/04 · 10b5-1 plan | Whalegun